ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 3164

Spondyloarthritis Pathogenesis Involves Interplay Between Gut Microbiota and Genetic Background

Tejpal Gill1, Mark Asquith2, Stephen Brooks3, James T. Rosenbaum2 and Robert A. Colbert1, 1National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD, 2Oregon Health & Science University, Portland, OR, 3NIAMS/NIH, Bethesda, MD

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: inflammatory bowel disease (IBD), microbiome and spondylarthropathy

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Wednesday, November 16, 2016

Title: Spondylarthropathies Psoriatic Arthritis – Pathogenesis, Etiology II

Session Type: ACR Concurrent Abstract Session

Session Time: 9:00AM-10:30AM

Background/Purpose: HLA-B27 and human b2m expression in rats induces a spontaneous inflammatory disease resembling human spondyloarthritis (SpA). While aspects of rat SpA have been studied in detail, understanding of gut inflammation remains limited. We recently showed that HLA-B27 affects the gut microbiota in rats. Here, we aimed to determine the relationship between intestinal microbiota and the gut immune response in B27 rats developing SpA-like disease.

Methods: HLA-B27/human b2m transgenic (B27) rats (33-3 transgene locus) on 3 genetic backgrounds (Dark Agouti, DA; Lewis, LEW; and Fischer, F344), and HLA-B7/human b2m transgenic (B7) rats on the LEW background, were examined at 2, 3, and 6 months of age. In a total of 194 rats, microbiota in the ileum, cecum and colon was determined by 16S rRNA gene sequencing. Cecum and colon histology was scored for inflammation, and RNA from whole tissue was analyzed by RNA-Seq to assess gene expression. Differences in microbiota and host immune response were identified as a function of genotype, genetic background, and disease severity.

Results: DA rats are resistant to B27-induced gut inflammation, while it progresses with age in LEW B27, and occurs early and is more severe in F344 rats. LEW B7 rats remain unaffected. Disease severity correlates with increased relative abundance of Proteobacteria and Verrucomicrobia at the expense of Firmicutes. While disease-associated microbes are similar in B27 LEW and F344, their relative frequencies are background specific. For example, Clostridium and Akkermansia are abundant in F344, while Prevotella and Sutterella exhibit greater increases in LEW. B27 DA and B7 LEW animals exhibit different microbial profiles compared to their WT controls, yet neither develops disease. Metagenome predictions revealed perturbed glutathione and steroid hormone biosynthesis B27 LEW and B27 F344. A striking finding was that LEW and F344 rats harbor segmented filamentous bacteria (SFB) in the ileum, whereas SFB are absent from the DA background and B7 LEW rats. Transcriptome analysis revealed robust activation of the IL-23/IL-17 axis, with IFN-g as well as TNF-a pathways upregulated with concomitant downregulation of metabolic pathways in B27 LEW and F344 rats. Interestingly, DA B27 showed a transient upregulation of these pathways including IL-17, IL-22, and TNF-a, but not IFN-g. LEW B7 rats had a remarkably similar transcriptome to LEW WT rats despite dramatic differences in microbial communities.

Conclusion: Integrated analysis of the gut microbiota and host transcriptome on different genetic backgrounds provides an unprecedented picture of the relationship between HLA-B27-induced gut inflammation and microbial communities. Microbial dysbiosis varies with genetic background, but contributes to a common disruption of gut metabolic pathways with activation of the IL-23/IL-17 axis, and IFN/TNF signaling leading to gut inflammation. The lack of SFB in DA rats may protect B27 animals given the well-known requirement for SFB for Th17 development in the lamina propria. Understanding SpA-associated microbial communities may lead to a better understanding of HLA-B27-associated disease pathogenesis.


Disclosure: T. Gill, None; M. Asquith, None; S. Brooks, None; J. T. Rosenbaum, Alcon Research Institute, Collins Medical Trust, Spondylitis Association of America, 2,AbbVie, UCB, XOMA, Santen, Novartis, Medimmune, Cavtherx, Portage, Topivert, Regeneron, Allergan, Sanofi, Gilead, Janssen, Genentech, Theravance, and Mallinckrodt, 5; R. A. Colbert, None.

To cite this abstract in AMA style:

Gill T, Asquith M, Brooks S, Rosenbaum JT, Colbert RA. Spondyloarthritis Pathogenesis Involves Interplay Between Gut Microbiota and Genetic Background [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/spondyloarthritis-pathogenesis-involves-interplay-between-gut-microbiota-and-genetic-background/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/spondyloarthritis-pathogenesis-involves-interplay-between-gut-microbiota-and-genetic-background/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology